V024-2691 Screening compound: 3,3-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide

V024-2691 Screening compound: 3,3-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide
V024-2691 Screening compound: 3,3-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-2691
3,3-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-2691

Molecular Formula

C28H44N4O4S (C28 H44 N4 O4 S)

Compound Name

3,3-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide

IUPAC name

33-dimethyl-N-({2-[(2-methylphenyl)methanesulfonyl]-1-(2-methylpropyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]butanamide

SMILES

CC(C)Cn1c(S(Cc2c(C)cccc2)(=O)=O)ncc1CN(CCN1CCOCC1)C(CC(C)(C)C)=O

InChI

InChI=1S/C28H44N4O4S/c1-22(2)19-32-25(18-29-27(32)37(34,35)21-24-10-8-7-9-23(24)3)20-31(26(33)17-28(4,5)6)12-11-30-13-15-36-16-14-30/h7-10,18,22H,11-17,19-21H2,1-6H3

InChI Key

HJLVUMMQDTXYMV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19820310

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

532.75

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.632

Distribution Coefficient, logD

4.598

Water Solubility, LogSw

-4.15

Polar Surface Area

68.476

Acid Dissociation Constant (pKa)

19.66

Base Dissociation Constant (pKb)

6.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

64.30

V024-2691 in Drug Discovery

Included in Screening Libraries

Anti-HIV1 Library (19540 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with V024-2691 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-2691?
Check Price and Availability of V024-2691, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-2691 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-2691
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-2691
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-2691 available by request